Unique ID issued by UMIN | UMIN000003542 |
---|---|
Receipt number | R000004240 |
Scientific Title | A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies |
Date of disclosure of the study information | 2010/05/01 |
Last modified on | 2013/04/26 16:37:22 |
A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies
KCOG-G1001s
A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies
KCOG-G1001s
Japan |
Brain metastases of gynecologic malignancies diagnosed with imaging modalities
Obstetrics and Gynecology |
Malignancy
NO
To clarify the clinical features, treatment modalities, and prognosis of patients with brain metastases of primary gynecoligic malignancies
Others
Retrospective study
Exploratory
Pragmatic
Not applicable
Age at diagnosis
Duration from the initial diagnosis to the recurrence
Duration from the initial diagnosis to the detection of brain metastases
Sites of brain metastases
Site and stage of primary disease
Pathological diagnosis of primary disease
Complication
Initial treatment for the primary disease
Effects of primary chemotherapy
Presence of pulmonary metastases
Sites of recurrence
Symptoms at recurrence
Neurological findings at diagnosis of brain metastases
Karnofsky Performance Status (KPS) and Recursive Partitioning Analysis (RPA)
Imaging modalities for the diagnosis of brain metastases
Numbers, Sites and size of brain metastases
Treatment modalities for brain metastases and their therapeutic effects and adverse effects
Status of neurologic symptoms after treatments
Prognosis
Cause of death
None
Observational
Not applicable |
Not applicable |
Female
Patients diagnosed as brain metastases of gynecologic malignancies from January, 1995 to December, 2009
Patients with pathologically confirmed gynecologic malignancies
Petients with history of non-gynecologic malignancies
Ptients with active non-gynecologic malignancy
Choriocarcinoma
Petients with history of treatment for central nervous system disease
100
1st name | |
Middle name | |
Last name | Kaei Nasu |
Oita University, Faculty of Medicine
Department of Obstetrics and Gynecology
Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita 879-5593, Japan
1st name | |
Middle name | |
Last name |
Oita University, Faculty of Medicine
Department of Obstetrics and Gynecology
http://www.kcog.jp/
Kansai Clinical Oncology Group
Kansai Clinical Oncology Group
Other
NO
2010 | Year | 05 | Month | 01 | Day |
Published
http://www.sciencedirect.com/science/article/pii/S0090825812008670
Mean survival time of the patients with brain metastases was 12.5 months for the ovarian cancer group, 6.2 months for the corpus cancer group, and 5.0 months for the cervical cancer group; two-year overall survival rates were 19.7%, 6.1%, and 4.8%, respectively. Multivariate analysis revealed ovarian/tubal/peritoneal origin, KPS >70, single brain metastasis, absence of extracranial disease, cranial surgery, cranial radiotherapy, and chemotherapy to be independent favorable prognostic factors associated with overall survival.
Completed
2010 | Year | 04 | Month | 23 | Day |
2010 | Year | 06 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2012 | Year | 04 | Month | 03 | Day |
Retrospective analysis of 139 patients with brain metastases from gynecologic malignancies was carried out as a multi-institutional study.
2010 | Year | 04 | Month | 26 | Day |
2013 | Year | 04 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004240